Financial results - CORMED HEMATOLOGIE CONSULTING SRL

Financial Summary - Cormed Hematologie Consulting Srl
Unique identification code: 36112927
Registration number: J23/2145/2016
Nace: 8622
Sales - Ron
37.088
Net Profit - Ron
29.799
Employees
Open Account
Company Cormed Hematologie Consulting Srl with Fiscal Code 36112927 recorded a turnover of 2024 of 37.088, with a net profit of 29.799 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Cormed Hematologie Consulting Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 2.677 31.543 38.998 40.401 28.316 47.145 91.139 37.088
Total Income - EUR - - 2.677 31.543 38.998 40.401 28.480 47.167 91.169 37.088
Total Expenses - EUR - - 253 452 559 623 687 705 745 1.613
Gross Profit/Loss - EUR - - 2.424 31.091 38.439 39.779 27.793 46.462 90.423 35.476
Net Profit/Loss - EUR - - 2.344 30.145 37.234 38.619 26.938 45.047 75.956 29.799
Employees - - 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -59.1%, from 91.139 euro in the year 2023, to 37.088 euro in 2024. The Net Profit decreased by -45.732 euro, from 75.956 euro in 2023, to 29.799 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Cormed Hematologie Consulting Srl

Rating financiar

Financial Rating -
CORMED HEMATOLOGIE CONSULTING...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Cormed Hematologie Consulting...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cormed Hematologie Consulting...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Cormed Hematologie Consulting...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cormed Hematologie Consulting Srl - CUI 36112927

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 4 0 0 0 0 0 0 0
Current Assets - - 2.577 33.137 38.162 39.323 27.199 45.611 84.437 31.659
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 0 3.319 3.672 5.500 2.123 502 20.811 21.727
Cash - - 2.577 29.818 34.491 33.823 25.076 45.109 63.626 9.932
Shareholders Funds - - 2.388 32.488 37.276 38.661 26.978 45.088 75.996 29.840
Social Capital - - 44 43 42 41 40 41 40 40
Debts - - 194 649 887 662 221 524 8.441 1.820
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 31.659 euro in 2024 which includes Inventories of 0 euro, Receivables of 21.727 euro and cash availability of 9.932 euro.
The company's Equity was valued at 29.840 euro, while total Liabilities amounted to 1.820 euro. Equity decreased by -45.732 euro, from 75.996 euro in 2023, to 29.840 in 2024.

Risk Reports Prices

Reviews - Cormed Hematologie Consulting Srl

Comments - Cormed Hematologie Consulting Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.